Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Mirabegron

Mirabegron

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Mirabegron

29 trials tracked of Mirabegron: 22 in phase 3 or 4 and 4 with published results. The most-cited published study has 66 citations.

29Trials tracked
22Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 4 12 Phase 3 10 Phase 2 7
  1. Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB) Completed · 66 cited
  2. Phase 3 Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity Completed · 29 cited
  3. Phase 4 Mirabegron and Urinary Urgency Incontinence Completed · 10 cited
  4. Phase 4 A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH) Completed · 5 cited
  5. Phase 4 Treatment of Incontinence Without Memory Problems Completed
  6. Phase 4 Mirabegron in Parkinson Disease and Impaired Cognition Completed
Show 23 more trials
  1. Phase 4 A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) Completed
  2. Phase 4 A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO) Completed
  3. Phase 4 A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants Completed
  4. Phase 4 A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder Completed
  5. Phase 4 Study of Behavioral Modification Program and Mirabegron to Improve Urinary Urgency in Multiple Sclerosis Completed
  6. Phase 4 A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients Completed
  7. Phase 4 A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB) Completed
  8. Phase 3 A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder Completed
  9. Phase 3 A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. Completed
  10. Phase 3 This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder Completed
  11. Phase 3 A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder Completed
  12. Phase 3 Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder Completed
  13. Phase 3 Add-on Mirabegron in Pediatric Patients With Refractory Overactive Bladder Completed
  14. Phase 3 Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder Completed
  15. Phase 3 Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder Completed
  16. Phase 3 A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder Completed
  17. Phase 2 Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain Completed
  18. Phase 2 A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder Completed
  19. Phase 2 Mirabegron For Erectile Dysfunction Completed
  20. Phase 2 The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury Completed
  21. Phase 2 MIrabegron and Physiological Function in Cold Environments Completed
  22. Phase 2 Mirabegron and Physiological Function in Cold Environments Completed
  23. Phase 2 A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO) Completed

Showing the 29 most-cited and recently-updated of 29 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.